LSD1-IN-34

• Target:

  Monoamine Oxidase|||Histone Demethylase|||TGF-beta/Smad

• Related Pathways:

  Stem Cells|||Neuroscience|||Chromatin/Epigenetic

• Bioactivity:

  LSD1-IN-34 (Compound 7d) is an orally effective inhibitor of lysine-specific demethylase (LSD) and monoamine oxidase (MAO), exhibiting IC50 values of 4.51 nM for LSD1 and 18.46 nM for MAO A. This compound inhibits activation of neonatal rat cardiac fibroblasts (NRCF) induced by angiotensin II (Ang II) and shows no significant toxicity at 20 ?M. LSD1-IN-34 also inhibits the TGF?/Smad signaling pathway, contributing to the improvement of heart failure in mice. Moreover, it demonstrates favorable pharmacokinetic properties in rats.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C